MedTrace Logo

Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception

NCT03512951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-12-20

No results posted yet for this study

Summary

Within the course of this study, a signal processing feature has been developed at Ecole Polytechnique Fédérale de Lausanne (EPFL), in collaboration with Sonova AG, in order to enhance the listening experience with remote microphone systems. In particular, the developed feature is supposed to improve the so-called audio-visual fusion, i.e. the fact to perceive the sound as coming from the physical location of the source. One of the main goals of the present study is to evaluate the extent to which this feature reaches that objective.

Conditions

  • Hearing Disorders
  • Hearing Loss, Sensorineural

Interventions

OTHER

Digital signal processing algorithms

The intervention consists in applying five processing on some recorded speech signals. In particular, the processing performed by one specific algorithm is compared against the four other. The applied processing is supposed to restore sound externalization (expected audio-visual fusion).

Sponsors & Collaborators

  • Gilles Courtois

    collaborator UNKNOWN

  • Vincent Grimaldi

    collaborator UNKNOWN

  • Eleftheria Georganti

    collaborator UNKNOWN

  • Peter Derleth

    collaborator UNKNOWN

  • David Sooprayen

    collaborator UNKNOWN

  • Sonova AG

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-09
Primary Completion
2018-11-27
Completion
2018-11-27

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03512951 on ClinicalTrials.gov